Skip to Main Content

Paper Details

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.
Acta Neuropathol
288
2020
IDH-mutant, IDH-mutant astrocytomas, astrocytomas
Author NameAffiliation
Daniel J BratRobert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Howard ColmanHuntsman Cancer Institute, University of Utah
Howard ColmanHuntsman Cancer Institute, University of Utah
Gregory N FullerUniversity of Texas MD Anderson Cancer Center
Gregory N FullerUniversity of Texas MD Anderson Cancer Center
Caterina GianniniMayo Clinic
Caterina GianniniMayo Clinic
Johan M KrosErasmus Medical Center
David N LouisMassachusetts General Hospital, Harvard Medical School
Arie PerryUniversity of California San Francisco
Arie PerryUniversity of California San Francisco
Guido ReifenbergerHeinrich Heine University
Guido Reifenberger
Roger StuppRobert H. Lurie Cancer Center, Malnati Brain Tumor Institute, Northwestern University Feinberg School of Medicine
Andreas von DeimlingInstitute of Pathology, University of Heidelberg
Andreas von DeimlingClinical Cooperation Unit Neuropathology, German Cancer Institute (DKFZ)
Michael WellerUniversity Hospital and University of Zurich
  • 1 - 19

Datasets